Tenaya Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Tenaya Therapeutics, Inc. (TNYA) reported Increase (Decrease) in Other Noncurrent Liabilities of $102.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-03-11
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-12-31 was -$14.00K, a 116.28% decline year-over-year.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-09-30 was $6.00K, a 93.55% decline year-over-year.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-06-30 was $5.00K.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-03-31 was $2.00K.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $102.00K.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $1.00K.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$1.00K, a 100.61% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $102.00K 10-K · filed 2026-03-11 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-11 | |||
| 2023-12-31 | $1.00K 10-K · filed 2025-03-10 | |||
| 2022-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$8.00K derived: sum of 2 quarters · filed 2024-03-18 | -$3.00K derived: sum of 3 quarters · filed 2024-03-18 | -$1.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $11.00K derived: sum of 2 quarters · filed 2023-11-08 | $13.00K 10-Q · filed 2023-11-08 | $99.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $7.00K 10-Q · filed 2023-08-09 | $93.00K derived: sum of 3 quarters · filed 2023-08-09 | $186.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-10 | $88.00K derived: sum of 2 quarters · filed 2023-05-10 | $181.00K derived: sum of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $179.00K derived: sum of 2 quarters · filed 2023-03-08 | $163.00K 10-K · filed 2023-03-08 | |
| 2021-09-30 | $93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $77.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$16.00K 10-Q · filed 2022-08-10 | |||
| 2020-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$18.00K derived: sum of 2 quarters · filed 2022-03-23 | -$34.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$24.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$16.00K 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |